
Glyphic Biotechnologies
Glyphic: A global consulting firm providing innovative business solutions with Fortune 1000 companies using top tech platforms.

Glyphic: A global consulting firm providing innovative business solutions with Fortune 1000 companies using top tech platforms.
Glyphic Biotechnologies, founded with the mission to revolutionize proteomics, focuses on advancing protein sequencing technology. The company aims to provide innovative solutions that enhance the understanding of protein structures and functions, thereby driving progress in biological research and medical diagnostics. Glyphic's core service is its cutting-edge protein sequencing technology, which targets researchers and organizations in the biotechnology and pharmaceutical industries.
Notable figures affiliated with Glyphic Biotechnologies include leading experts in proteomics and biotechnology. The company has garnered attention from prominent investors in the biotech sector, contributing to its rapid growth and development. Key achievements include significant advancements in protein sequencing accuracy and efficiency, positioning Glyphic as a leader in the field. The overall impact of Glyphic Biotechnologies lies in its potential to transform proteomics research, leading to breakthroughs in disease understanding and drug development.
Companies similar to Glyphic Biotechnologies include GMJ Technologies, Erisyon, Encodia and Quantum-Si.
Glyphic Biotechnologies was founded in 2021.
Glyphic Biotechnologies' headquarters is located in New York City, NY, US.
Glyphic Biotechnologies' most recent funding round was for $408.9k (USD) in September 2023.
As of Sep 14, 2023, Glyphic Biotechnologies has disclosed funding of $10.6M (USD). Undisclosed round amounts are excluded.
Glyphic Biotechnologies has 25 employees as of Feb 4, 2024.

Quantum-Si
quantum-si.com